Status:
COMPLETED
Treatment of PED With AMT and Autologous Serum
Lead Sponsor:
King Khaled Eye Specialist Hospital
Conditions:
Corneal Epithelial Defect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%...
Eligibility Criteria
Inclusion
- Corneal epithelial defect of more than 14 days that has not responded to conventional therapy
Exclusion
- Under age 18
- Pregnant/lactating females
- Patients with hemoglobin levels \< 12 mg/ml
- Patients with limbal stem cell deficiency
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00238862
Start Date
October 1 2005
End Date
September 1 2006
Last Update
December 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Khaled Eye Specialist Hospital
Riyadh, Saudi Arabia, 11462